Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-15 · accession 0001415889-25-004506 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-18 | 2025-02-15+ | HALO | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +122.8K | 744.5K | +20% | $0 |
| DM | 2025-02-18 | 2025-02-15+ | HALO | Torley Helen | Pres AND CEO, Dir | F - Tax | $58.29 | -66.2K | 705.9K | -9% | -$3.86M |
| DM | 2025-02-18 | 2025-02-15+ | HALO | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | -122.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-16 | M | A | 21,009 | $0.00 | 726,889 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-16 | F | D | 11,313 | $58.29 | 715,576 | D | — | — | (F3) The reported disposition of 11,313 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 3 | Common | Common Stock | 2025-02-16 | M | A | 16,875 | $0.00 | 732,451 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-16 | F | D | 9,087 | $58.29 | 723,364 | D | — | — | (F4) The reported disposition of 9,087 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 5 | Common | Common Stock | 2025-02-15 | M | A | 13,092 | $0.00 | 679,836 | D | — | — | |
| 6 | Common | Common Stock | 2025-02-15 | F | D | 7,098 | $58.29 | 672,738 | D | — | — | (F1) The reported disposition of 7,098 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 7 | Common | Common Stock | 2025-02-16 | M | A | 71,810 | $0.00 | 744,548 | D | — | — | |
| 8 | Common | Common Stock | 2025-02-16 | F | D | 38,668 | $58.29 | 705,880 | D | — | — | (F2) The reported disposition of 38,668 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 9 | Derivative | Restricted Stock Units | 2025-02-15 | M | D | 13,092 | $0.00 | 0 | D | $0.00 · — to — | 13,092 Common Stock | (F5) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 10 | Derivative | Restricted Stock Units | 2025-02-16 | M | D | 16,875 | $0.00 | 33,749 | D | $0.00 · — to — | 16,875 Common Stock | (F5) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 11 | Derivative | Restricted Stock Units | 2025-02-16 | M | D | 21,009 | $0.00 | 21,009 | D | $0.00 · — to — | 21,009 Common Stock | (F5) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 12 | Derivative | Performance Stock Units | 2025-02-16 | M | D | 71,810 | $0.00 | 0 | D | $0.00 · — to — | 71,810 Common Stock | (F6) This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer. |